ID Genomics, Inc. has been awarded a National Institute of Health (NIH) Small Business Technology Transfer Phase II Research grant to advance its clonotyping technology for detecting and monitoring drug-resistant bacteria. The grant provides IDG with $2,938,488 through 2019, starting in the [...]
Researchers at ID Genomics, Inc. have discovered that that thousands of disease-causing E. coli strains simplify into several dozens of families with distinct responses to antibiotics. IDG has developed a unique “barcode” to identify each of these families, using only a handful of genetic [...]